Adimab’s Engineering-Driven Toolkit for Next-Generation T-Cell Engagers
12:00 pm - Wednesday 10th June 2026
- Introducing innovative heterodimerization designs, advanced antibody discovery workflows, and refined CD3 binding lineages
- Showcasing seamless platforms for T-cell engager formatting, production, and characterization
- Highlighting how engineering-first approaches drive faster development of superior TCE candidates for partners
